Design and synthesis of novel and potent amide linked PPARγ/δ dual agonists

Design and synthesis of novel and potent amide linked PPARγ/δ dual agonists Design and synthesis of a novel class of dual PPARγ/δ agonists Design and Synthesis of Dual Peroxisome Proliferator-Activated Receptors γ and δ Agonists as Novel Euglycemic Agents with a Reduced Weight Gain Profile Design, synthesis and evaluation of novel zwitterionic compounds as PPARα/γ dual agonists (1) Discovery of a Novel Series of Peroxisome Proliferator-Activated Receptor α/γ Dual Agonists for the Treatment of Type 2 Diabetes and Dyslipidemia 5-Aryl thiazolidine-2,4-diones: discovery of PPAR dual α/γ agonists as antidiabetic agents Design, synthesis, and evaluation of 2-alkoxydihydrocinnamates as PPAR agonists Discovery of a Peroxisome Proliferator Activated Receptor γ (PPARγ) Modulator with Balanced PPARα Activity for the Treatment of Type 2 Diabetes and Dyslipidemia (S)-3-(4-(2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)-2-(piperazin-1-yl)propanoic acid compounds: Synthesis and biological evaluation of dual PPARα/γ agonists Aryloxazolidinediones: identification of potent orally active PPAR dual α/γ agonists